My Account |

Human Apolipoprotein C-I (Apo C1) ELISA Kit

Name: Human Apolipoprotein C-I (Apo C1) ELISA Kit
Brand: AssayMax&trade; ELISA Kits
SKU: EA8011-2
Availability: InStock

$407.00

Catalog Number: EA8011-2

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Catalog Number. EA8011-2 Categories: ELISA Kits, Kits, Sandwich ELISA Tags: APO C1, Apo-CI, ApoC-I, APOC1, Apolipoprotein C-I, Apolipoprotein C1, Truncated Apolipoprotein C-I Brand: AssayMax™ ELISA Kits

Additional information

Format	Sandwich ELISA
Entrez Gene	341
Components	Biotinylated Human Apolipoprotein C-I Antibody, Chromogen Substrate (1x), EIA Diluent Concentrate (10x), Human Apolipoprotein C-I Microplate, Human Apolipoprotein C-I Standard, Sealing Tapes, SP Conjugate (100x), Stop Solution (1x), Wash Buffer Concentrate (20x)
TIme	4 hours
Sensitivity	25 ng/ml
Range	0.031 – 2 ug/ml
Samples Type	Plasma, Serum
Associated Disease	Cancer, Cardiovascular, Heart Disease
Species	Human
UniProt	P02654
Storage	Refer to component labels for details
Plex	1
Usage	For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications

"* Hu Y et al. (2021) Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer's disease. J Lipid Res. 62:100014.
"* Odaka A (2018) Examination of external and internal factors for the pathophysiology of pediatric idiopathic steroid-sensitive nephrotic syndrome. Jichi Medical University.
"* Nicola WG et al. (2018) Protective effect of inulin and the integrity of the microvasculature in diabetes mellitus. Biomed. Pharm. J. 11(2):807-813.
"* Odaka J et al. (2017) Apolipoprotein C-I Levels Are Associated with the Urinary Protein/Urinary Creatinine Ratio in Pediatric Idiopathic Steroid-Sensitive Nephrotic Syndrome: A Case Control Study. Int J Nephrol. 2017:6392843.
"* Broek I et al. (2016) Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping. Clin Chem. 62(1):188-97.
"* Basak T et al. (2016) Plasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathway. Sci Rep. 6:28042.
"* Yan LR et al. (2014) A Pro-Atherogenic HDL Profile in Coronary Heart Disease Patients: An iTRAQ Labelling-Based Proteomic Approach. PLoS One. 9(5):e98368. doi: 10.1371/journal.pone.0098368. eCollection 2014
"* Kupervaser-Cohen M (2011) MALDI-Based Serum Peptide Signature Discriminating Stomach and Pancreas Adenocarcinoma Patients from Cancer-Free Controls: Adjustment to Diagnosis with Immuno-Based Assays. Ben-Gurion University of the Negev. PhD Thesis.
"* Hansen JB et al. (2011) The Apolipoprotein C-I Content of Very-Low-Density Lipoproteins Is Associated with Fasting Triglycerides, Postprandial Lipemia, and Carotid Atherosclerosis. J Lipids. 2011:271062.
"* Cohen M et al. (2011) Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays. PLoS One 6(1): e14540
"* Xue A et al. (2010) Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis. Br. J. Cancer 103(3):391-400

Human Apolipoprotein C-I (Apo C1) ELISA Kit

Additional information

Documentation

Publications

Related products

Human Apolipoprotein C-I (Apo C1) ELISA Kit (with Control)

Human Apolipoprotein C-I (Apo C1) ELISA Kit (with Control)

Human Apolipoprotein C-I (Apo C1) ELISA Kit Positive Reference Plasma Control

Human Apolipoprotein C-I (Apo C1) ELISA Kit